Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

FBRXFBRX
4 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in Forte Biosciences Inc.

CITADEL ADVISORS LLC holds 547,415 shares of FBRX (Forte Biosciences Inc.), worth $11.6M as of 2026-Q2. The position was increased (+134.6% shares). FBRX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$11.6M

Current Shares

547,415

Total Value Change

+$11.4M

Total Shares Change

+531,782

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
547,415
+134.6%
$11.6M0.0%$21.25
45
2026-Q1
New
233,369
-
$6M0.0%$30.42
38
2025-Q4
Exited
0
-100.0%
$00.0%$26.27
0
2025-Q3
New
15,633
-
$234,4950.0%$14.48
35

Other major holders of FBRX: FEDERATED HERMES, INC., FRED ALGER MANAGEMENT, LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used